Open Access Open Access  Restricted Access Subscription Access

Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies

Sujata ., Sakshi Tyagi

Abstract


Antimicrobial resistance (AMR) represents a critical and rapidly escalating threat to global health, food security, and economic development. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve mechanisms to resist the effects of antimicrobial agents designed to eliminate them. The increasing misuse and overuse of antibiotics in human medicine, veterinary practice, and agriculture have significantly accelerated the emergence and dissemination of resistant strains. Consequently, infections that were once easily treatable are becoming increasingly difficult to manage, leading to prolonged illness, increased mortality, and escalating healthcare costs.

Mechanistically, AMR arises through multiple pathways, including enzymatic drug degradation, modification of drug targets, activation of efflux pumps, and reduced cellular permeability. Horizontal gene transfer further amplifies resistance dissemination among microbial populations. Globally significant resistant pathogens include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Mycobacterium tuberculosis.

Management strategies for AMR involve a multifaceted approach encompassing antimicrobial stewardship programs, infection prevention and control measures, surveillance systems, development of novel antimicrobial agents, and alternative therapies such as bacteriophage therapy and immunotherapy. Advances in molecular diagnostics, genomics, and artificial intelligence have enhanced early detection and targeted treatment approaches.

Despite these efforts, challenges such as inadequate global surveillance, limited drug development pipelines, economic constraints, and lack of public awareness persist. This review provides a comprehensive overview of AMR, including its epidemiology, mechanisms, clinical impact, and management strategies, highlighting the urgent need for coordinated global interventions.


Full Text:

PDF

References


World Health Organization. Antimicrobial resistance. 2023.

WHO GLASS Report. 2022.

Blair JM, et al. Nat Rev Microbiol. 2015;13:42–51.

Munita JM, Arias CA. Microbiol Spectr. 2016.

CDC. Antibiotic resistance threats. 2022.

CDC Antimicrobial Stewardship. 2025.

Obermeyer Z. N Engl J Med. 2016.

Holmes AH. Lancet. 2016.

Davies J. Microbiol Mol Biol Rev. 2010.

WHO Report. 2023.


Refbacks

  • There are currently no refbacks.